| William H Liggett, MD | |
|
3443 Dickerson Pike, Ste 760, Nashville, TN 37207-2519 | |
| (615) 890-1556 | |
| (615) 860-1558 |
| Full Name | William H Liggett |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 33 Years |
| Location | 3443 Dickerson Pike, Nashville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336230424 | NPI | - | NPPES |
| 900002927 | Other | RR MEDICARE | |
| 3847763 | Medicaid | TN | |
| 3640183 | Other | UNITED HEALTHCARE | |
| 5949664 | Other | AETNA | |
| 3136276 | Other | TN | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 32217 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tristar Skyline Medical Center | Nashville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tennessee Oncology, Pllc | 4688586134 | 223 |
News Archive
Boehringer Ingelheim will present results from LUX-Lung 3, the company's pivotal Phase III clinical trial investigating afatinib in patients with stage IIIB or IV non-small cell lung cancer (NSCLC) harboring an epidermal growth factor receptor (EGFR) mutation (EGFR M+), at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 1-5, 2012.
The latest research on hearing loss, head and neck cancers, sleep apnea and other otolaryngic topics will be presented in Dallas, TX, September 27-30, at the 2015 Annual Meeting & OTO EXPO? of the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF), the largest annual meeting of ear, nose, throat, head and neck physicians in the world.
Around 13 per cent of hospitals have a primary care unit within the emergency department and 6 per cent have a free standing primary care unit.
A team of researchers led by Kath Bogie, DPhil (PhD), a biomedical engineer and associate professor of orthopaedics and biomedical engineering at Case Western Reserve University School of Medicine, and colleagues from Case Western Reserve and other institutions, has received a $1.8M, three-year grant from the U.S. Department of Defense to develop an implantable muscle stimulator for preventing pressure ulcers and deep tissue injuries to the buttocks.
Nasal surgery appears to effectively create feminine facial profiles in patients undergoing male-to-female gender reassignment, according to a report in the September/October issue of Archives of Facial Plastic Surgery.
› Verified 6 days ago
| Entity Name | Tennessee Oncology, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811955917 PECOS PAC ID: 4688586134 Enrollment ID: O20031103000534 |
News Archive
Boehringer Ingelheim will present results from LUX-Lung 3, the company's pivotal Phase III clinical trial investigating afatinib in patients with stage IIIB or IV non-small cell lung cancer (NSCLC) harboring an epidermal growth factor receptor (EGFR) mutation (EGFR M+), at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 1-5, 2012.
The latest research on hearing loss, head and neck cancers, sleep apnea and other otolaryngic topics will be presented in Dallas, TX, September 27-30, at the 2015 Annual Meeting & OTO EXPO? of the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF), the largest annual meeting of ear, nose, throat, head and neck physicians in the world.
Around 13 per cent of hospitals have a primary care unit within the emergency department and 6 per cent have a free standing primary care unit.
A team of researchers led by Kath Bogie, DPhil (PhD), a biomedical engineer and associate professor of orthopaedics and biomedical engineering at Case Western Reserve University School of Medicine, and colleagues from Case Western Reserve and other institutions, has received a $1.8M, three-year grant from the U.S. Department of Defense to develop an implantable muscle stimulator for preventing pressure ulcers and deep tissue injuries to the buttocks.
Nasal surgery appears to effectively create feminine facial profiles in patients undergoing male-to-female gender reassignment, according to a report in the September/October issue of Archives of Facial Plastic Surgery.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William H Liggett, MD Po Box 440100, Nashville, TN 37244-0100 Ph: (615) 329-0570 | William H Liggett, MD 3443 Dickerson Pike, Ste 760, Nashville, TN 37207-2519 Ph: (615) 890-1556 |
News Archive
Boehringer Ingelheim will present results from LUX-Lung 3, the company's pivotal Phase III clinical trial investigating afatinib in patients with stage IIIB or IV non-small cell lung cancer (NSCLC) harboring an epidermal growth factor receptor (EGFR) mutation (EGFR M+), at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 1-5, 2012.
The latest research on hearing loss, head and neck cancers, sleep apnea and other otolaryngic topics will be presented in Dallas, TX, September 27-30, at the 2015 Annual Meeting & OTO EXPO? of the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF), the largest annual meeting of ear, nose, throat, head and neck physicians in the world.
Around 13 per cent of hospitals have a primary care unit within the emergency department and 6 per cent have a free standing primary care unit.
A team of researchers led by Kath Bogie, DPhil (PhD), a biomedical engineer and associate professor of orthopaedics and biomedical engineering at Case Western Reserve University School of Medicine, and colleagues from Case Western Reserve and other institutions, has received a $1.8M, three-year grant from the U.S. Department of Defense to develop an implantable muscle stimulator for preventing pressure ulcers and deep tissue injuries to the buttocks.
Nasal surgery appears to effectively create feminine facial profiles in patients undergoing male-to-female gender reassignment, according to a report in the September/October issue of Archives of Facial Plastic Surgery.
› Verified 6 days ago
Megan Desai, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4220 Harding Pike, Nashville, TN 37205 Phone: 615-222-6726 Fax: 615-222-3702 | |
Harrison Klause, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
John N Bowers, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4230 Harding Pike Ste 500, Nashville, TN 37205 Phone: 629-255-2493 Fax: 629-255-4266 | |
Dr. Evan Zehr, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1161 21st Ave S, Nashville, TN 37232 Phone: 615-322-6943 | |
Spurthi N Bhatt, MD MPH Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Mr. Robert M Johnson, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2410 Patterson St, Suite 106, Nashville, TN 37203 Phone: 615-340-4611 Fax: 615-340-4658 | |
Mr. John E Anderson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2400 Patterson St, Suite 400, Nashville, TN 37203 Phone: 615-342-5900 Fax: 615-342-5912 |